戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  disease, amyotrophic lateral sclerosis, and alpha-1 antitrypsin deficiency).
2 tment of a registry for subjects with severe alpha 1-antitrypsin deficiency.
3 ing neutrophil elastase for the treatment of alpha-1 antitrypsin deficiency.
4 tional diseases such as cystic fibrosis, and Alpha-1 antitrypsin deficiency.
5 type, causes a liver and lung disease called alpha-1 antitrypsin deficiency.
6 ung diseases such as bacterial infection and alpha-1 antitrypsin deficiency.
7 vel strategy for the perinatal management of alpha-1 antitrypsin deficiency.
8 ions in noncoding gene regions may result in alpha-1-antitrypsin deficiency.
9 ases of the lung, namely cystic fibrosis and alpha-1-antitrypsin deficiency.
10 re, early-onset COPD, who do not have severe alpha-1-antitrypsin deficiency.
11 r aggregation and lung-disease phenotypes of alpha-1-antitrypsin deficiency.
12 olymers at the site of synthesis, leading to alpha-1-antitrypsin deficiency.
13 n, and underlies misfolding diseases such as alpha(1)-antitrypsin deficiency.
14 wn as SERPINA1) gene that is responsible for alpha(1)-antitrypsin deficiency.
15 6 male and 4 female former smokers, two with alpha(1)-antitrypsin deficiency.
16 rs that can be used to treat patients with Z alpha(1)-antitrypsin deficiency.
17 opean descent and accounts for 95% of severe alpha(1)-antitrypsin deficiency.
18 liver failure included biliary atresia (11), alpha 1-antitrypsin deficiency (1), and liver failure se
19 ter before LTx could be analysed (COPD, 360; alpha-1-antitrypsin deficiency, 127; interstitial lung d
20                     In the classical form of alpha(1)-antitrypsin deficiency, a mutant protein accumu
21 ed with bile acid synthetic disorder (BASD), alpha-1 antitrypsin deficiency (A1AT), chronic intrahepa
22 children with biliary atresia (BA; n = 187), alpha-1 antitrypsin deficiency (A1AT; n = 78), and Alagi
23                                              Alpha-1 antitrypsin deficiency (A1ATD) is a life-threate
24                         Liver disease due to alpha-1-antitrypsin deficiency (A1ATD) is associated wit
25                                              alpha(1)-Antitrypsin deficiency (AATD) is an inherited d
26                                              Alpha-1 antitrypsin deficiency (AATD) can manifest at an
27                                              Alpha-1 antitrypsin deficiency (AATD) is a rare autosoma
28                                              Alpha-1 antitrypsin deficiency (AATD) is a rare genetic
29                                              Alpha-1 antitrypsin deficiency (AATD) is among the most
30                Rationale: The ZZ genotype of alpha-1 antitrypsin deficiency (AATD) is associated with
31                                              Alpha-1 antitrypsin deficiency (AATD) is commonly caused
32                                              Alpha-1 antitrypsin deficiency (AATD) is most commonly c
33                                              Alpha-1 antitrypsin deficiency (AATD) liver disease is c
34 rypsin (IV-AAT) has been used as therapy for alpha-1 antitrypsin deficiency (AATD) since 1987.
35 nts with PiZZ/PNPLA3 I148M from the European alpha-1-antitrypsin deficiency (AATD) liver consortium a
36 e impact of the local folding environment in alpha-1-antitrypsin deficiency (AATD), Niemann-Pick type
37 sthma is more common in subjects with severe alpha 1-antitrypsin deficiency (alpha 1-ATD) and airway
38  was limited to Mendelian syndromes, such as alpha-1 antitrypsin deficiency and cutis laxa, caused by
39                   The conference was titled "Alpha-1-Antitrypsin Deficiency and Other Liver Diseases
40 ith severe, early-onset COPD (without severe alpha(1)-antitrypsin deficiency) and 348 of their first-
41 as up-regulated in livers from patients with alpha(1)-antitrypsin deficiency, and the degree of up-re
42 n 3000 individuals in the United States have alpha-1 antitrypsin deficiency, and the most common caus
43  Wilson disease, genetic hemochromatosis and alpha-1 antitrypsin deficiency as we continue to elucida
44                                              Alpha-1 antitrypsin deficiency associated liver disease
45                                              alpha-1 Antitrypsin deficiency-associated liver disease
46 amilial aggregation for COPD, independent of alpha-1-antitrypsin deficiency, could be demonstrated.
47 prevalence is comparable to the frequency of alpha-1 antitrypsin deficiency documented in this popula
48         The polymerization of AT, leading to alpha(1)-antitrypsin deficiency, has been studied extens
49                                           In alpha-1 antitrypsin deficiency, hepatocytes accumulate d
50 monary disorders, including cystic fibrosis, alpha 1-antitrypsin deficiency, hereditary hemorrhagic t
51 afe genetic correction of a mutation causing alpha-1 antitrypsin deficiency in patient-derived hPSCs.
52      We compared data of patients with COPD, alpha-1-antitrypsin deficiency, interstitial lung diseas
53 ene-by-smoking interactions, but only severe alpha 1-antitrypsin deficiency is a proven genetic risk
54                                              Alpha-1-antitrypsin deficiency is a genetic condition as
55 over 65 million individuals worldwide, where alpha-1-antitrypsin deficiency is a major genetic cause
56                                       Severe alpha-1-antitrypsin deficiency is the only proven geneti
57 result from mutations in the genes SERPINA1 (alpha(1)-antitrypsin deficiency), JAG1 (Alagille syndrom
58                                              alpha-1-antitrypsin deficiency leads to chronic obstruct
59 ive effects of multiple SERPINA1 variants on alpha-1 antitrypsin deficiency, lung function, and emphy
60   In addition to Mendelian syndromes such as alpha-1 antitrypsin deficiency, many genomic regions tha
61 ticulum Hsp90 chaperone paralog, in managing alpha-1-antitrypsin deficiency on a residue-by-residue b
62             In our study of 57 patients with alpha-1 antitrypsin deficiency (phenotype PiZ), progress
63  distinct form of "ER stress" that occurs in alpha(1)-antitrypsin deficiency, presumably determined b
64                             The diagnosis of alpha 1-antitrypsin deficiency should be considered in p
65                                              Alpha-1 antitrypsin deficiency shows that rare coding va
66 iectasis may be more common in patients with alpha 1-antitrypsin deficiency than has been previously
67                                           In alpha(1)-antitrypsin deficiency, the pathogenic Z varian
68                              Yet, aside from alpha-1 antitrypsin deficiency, the genetic determinants
69 , vascular (type IV) Ehlers-Danlos syndrome, alpha-1 antitrypsin deficiency, tuberous sclerosis compl
70                 CT scans in 14 patients with alpha 1-antitrypsin deficiency were evaluated by two tho
71 tor, low levels of which are associated with alpha-1 antitrypsin deficiency which leads to liver dise